knowledge -WSS

knowledge

author：fashion 2025-09-28 08:53:20 - browse：37

SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and reviewed by STAT.

The layoffs, which began last Wednesday, impact research teams across the company’s California sites in San Diego and Foster City, as well as locations in Madison, Wisconsin; Singapore; and the United Kingdom. Alex Aravanis, the company’s chief technology officer, noted in an internal message that these cuts affect a tenth of research and development staff. The company’s also planning to shut down all lab-based research and development work in Foster City, according to a note from Steve Barnard, vice president of technology development.

Barnard’s note mentions that all affected employees have already been notified. And a separate message from interim CEO Charles Dadswell makes clear last week’s layoffs won’t be the last.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： The cancer drug shortage isn’t new — and neither are the solutions

WSS

Guidelines to prevent youth baseball injuries need more muscle

Heart disease and mental health: A look at cardiac psychology

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

At least 13 dead in Texas as scorching temps continue

As demand for Covid shots wanes, Moderna seeks its next success

Guidelines to prevent youth baseball injuries need more muscle

Wikipedia

knowledge

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

Walensky prepares to leave CDC — and Congress — behind

Dobbs anniversary: the lost opportunity of abortion as health care

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Alkermes shareholders re

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

New air purifier tech could be key to improving indoor air quality

Readout LOUD podcast: live from JPM 2024

Peter Hotez and the public health issue of online harassment

Hepatitis C has a cure — but many Americans still lack access to it

focus

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Designating disabled people as health disparity population is crucial

Malaria cases in Florida and Texas: Here’s what you need to know

HHS names first

The nurse manager staffing crisis is hurting patients

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

hotspot

entertainment

Wikipedia

knowledge